Alx Oncology Holdings Inc
(ALXO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 363,667 | 385,149 | 409,964 | 429,855 | 434,219 |
| TOTAL | $367,019 | $388,963 | $412,277 | $432,327 | $435,992 |
| Non-Current Assets | |||||
| PPE Net | 897 | 562 | 167 | 47 | 52 |
| Other Non-Current Assets | 12,267 | 10,203 | 8,845 | 536 | 10 |
| TOTAL | $13,164 | $10,765 | $9,012 | $583 | $62 |
| Total Assets | $380,183 | $399,728 | $421,289 | $432,910 | $436,054 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,394 | 5,278 | 6,594 | 7,350 | 76 |
| Accrued Expenses | 9,901 | 7,210 | 7,385 | 6,779 | 6,128 |
| TOTAL | $15,295 | $12,488 | $13,979 | $14,129 | $6,204 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,839 | 2,068 | 2,296 | 297 | 5 |
| TOTAL | $1,839 | $2,068 | $2,296 | $297 | $5 |
| Total Liabilities | $17,134 | $14,556 | $16,275 | $14,426 | $6,209 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,631 | 40,500 | 40,343 | 40,230 | 40,127 |
| Common Shares | 41 | 40 | 40 | 40 | 40 |
| Retained earnings | -201,985 | -173,547 | -148,981 | -132,707 | -118,522 |
| TOTAL | $363,049 | $385,172 | $405,014 | $418,484 | $429,845 |
| Total Liabilities And Equity | $380,183 | $399,728 | $421,289 | $432,910 | $436,054 |